공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 인간 간 모델 시장

Human Liver Models

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997476
페이지 정보 영문 189 Pages
가격
US $ 4,950 ₩ 5,625,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 16,875,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 인간 간 모델 시장 Human Liver Models
발행일 : 2021년 04월 페이지 정보 : 영문 189 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 인간 간 모델 시장 규모는 분석기간(2020-2027년)에 12.3%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 17억 달러에서 2027년에는 39억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 간 오가노이드는 분석기간 중 11.6%의 CAGR을 나타내고, 7억 8,820만 달러에 달할 전망입니다.

세계의 인간 간 모델(Human Liver Models) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Ascendance Biotechnology, Inc.
  • CN Bio Innovations Ltd.
  • Cyfuse Biomedical K.K.
  • Emulate, Inc.
  • Organovo Holdings, Inc.

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 인간 간 모델 시장 : 개요
    • 약물 요법 : 간경변 및 기타 만성 간질환
    • 선천성 간질환 및 간조직 이식 치료의 발전
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

IV. 경쟁

  • 기업 개요 : 42개사
LSH 21.04.08

Abstract:

Global Human Liver Models Market to Reach $3.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Human Liver Models estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027. Liver Organoids, one of the segments analyzed in the report, is projected to record a 11.6% CAGR and reach US$788.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liver-on-a-chip segment is readjusted to a revised 13.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $462.8 Million, While China is Forecast to Grow at 15.9% CAGR

The Human Liver Models market in the U.S. is estimated at US$462.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$838 Million by the year 2027 trailing a CAGR of 15.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.8% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

2D Models Segment to Record 12.3% CAGR

In the global 2D Models segment, USA, Canada, Japan, China and Europe will drive the 11.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$205.5 Million in the year 2020 will reach a projected size of US$439.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$572.6 Million by the year 2027, while Latin America will expand at a 13.8% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -

  • Ascendance Biotechnology, Inc.
  • CN Bio Innovations Ltd.
  • Cyfuse Biomedical K.K.
  • Emulate, Inc.
  • Organovo Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Human Liver Model Market: Overview
    • Drug Therapies - Cirrhosis & Other Chronic Liver Diseases
    • Advances in Treating Congenital Liver Diseases and Liver Tissue Transplantation
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Human Liver Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Human Liver Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Liver Organoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Liver Organoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liver Organoids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Liver-on-a-chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Liver-on-a-chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Liver-on-a-chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for 2D Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for 2D Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for 2D Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Animal Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Animal Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Animal Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 19: USA Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 20: USA Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: USA 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 22: Canada Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 23: Canada Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: Canada 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 25: Japan Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Japan Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: Japan 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 28: China Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: China Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: China 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 31: Europe Current & Future Analysis for Human Liver Models by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe Historic Review for Human Liver Models by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Europe 15-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 34: Europe Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Europe Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Europe 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 37: France Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: France Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: France 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 40: Germany Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Germany Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Germany 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 43: Italy Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Italy Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Italy 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 46: UK Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: UK Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: UK 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 49: Spain Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Spain Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Spain 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 52: Russia Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Russia Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Russia 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 55: Rest of Europe Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Rest of Europe Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Rest of Europe 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 58: Asia-Pacific Current & Future Analysis for Human Liver Models by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 59: Asia-Pacific Historic Review for Human Liver Models by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Asia-Pacific 15-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 61: Asia-Pacific Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Asia-Pacific Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Asia-Pacific 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 64: Australia Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Australia Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Australia 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 67: India Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: India Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: India 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 70: South Korea Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: South Korea Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: South Korea 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 73: Rest of Asia-Pacific Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Rest of Asia-Pacific Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Rest of Asia-Pacific 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 76: Latin America Current & Future Analysis for Human Liver Models by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 77: Latin America Historic Review for Human Liver Models by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Latin America 15-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 79: Latin America Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Latin America Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Latin America 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 82: Argentina Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Argentina Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Argentina 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 85: Brazil Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Brazil Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Brazil 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 88: Mexico Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Mexico Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Mexico 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 91: Rest of Latin America Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of Latin America Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of Latin America 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 94: Middle East Current & Future Analysis for Human Liver Models by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 95: Middle East Historic Review for Human Liver Models by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Middle East 15-Year Perspective for Human Liver Models by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 97: Middle East Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Middle East Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Middle East 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 100: Iran Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Iran Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Iran 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 103: Israel Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Israel Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Israel 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 106: Saudi Arabia Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Saudi Arabia Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Saudi Arabia 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 109: UAE Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UAE Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UAE 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 112: Rest of Middle East Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Rest of Middle East Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Rest of Middle East 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 115: Africa Current & Future Analysis for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Africa Historic Review for Human Liver Models by Type - Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Africa 15-Year Perspective for Human Liver Models by Type - Percentage Breakdown of Value Sales for Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models and 3D Bioprinting for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42
Back to Top
전화 문의
F A Q